SCN1A and SCN2A are associated with a variety of epilepsy syndromes; most notably, Dravet syndrome is caused by an SCN1A mutation in over 80% of reported cases [2, 3]. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.